Personal information

Verified email addresses

Activities

Works (33)

Efficacy and Safety of Phoenix dactylifera L. Leaf Extract (WartOver®) in the Treatment of Cutaneous Warts: A Randomized, Double-Blind, Placebo-Controlled Trial

Dermatologic Therapy
2024 | Journal article
EID:

2-s2.0-85192712437

Part of ISSN: 15298019 13960296
Contributors: Ayatollahi, A.; Firooz, A.; Shakoei, S.; Robati, R.M.; Aramipour, N.; Sadeghi, S.; Tavakoli-Far, F.; Reza Niavand, M.; Saber, M.; Fattahi, M. et al.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

LRRK2; Communicative Role in the Treatment of Parkinson’s Disease and Ulcerative Colitis Overlapping

CNS and Neurological Disorders - Drug Targets
2024 | Journal article
EID:

2-s2.0-85198963753

Part of ISSN: 19963181 18715273
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Niknejad, A.; Shamsnia, H.S.; Shayan, M.; Shalmani, L.M.; Momtaz, S.; Rezaei, N.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Spinal Muscular Atrophy Treatment: The MTOR Regulatory Intervention

Current Medicinal Chemistry
2024 | Journal article
EID:

2-s2.0-85184265326

Part of ISSN: 1875533X 09298673
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Shayan, M.; Eshraghi, S.; Momtaz, S.; Jamialahmadi, T.; Abdolghaffari, A.H.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders

Current Pharmaceutical Biotechnology
2024 | Journal article
EID:

2-s2.0-85199300090

Part of ISSN: 18734316 13892010
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Shahraki, F.N.; Zandi, N.; Pazoki, B.; Farzaei, M.H.; Ghasemi, M.; Abdollahi, M.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway

Naunyn-Schmiedeberg's Archives of Pharmacology
2024 | Journal article
EID:

2-s2.0-85171794944

Part of ISSN: 14321912 00281298
Contributors: Lashgari, N.-A.; Khayatan, D.; Roudsari, N.M.; Momtaz, S.; Dehpour, A.R.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 2)‎

Assessment of Transcription Errors and their Effects on Medical Approach, Hospitalization Duration, and Financial Costs of Traumatic Patients: How Can We Prevent Them?

Epidemiology and Health System Journal
2024-11-12 | Journal article
Contributors: Ramin Abrishami; Seyed Hadi Aghili; Mehri Farhang Ranjbar; Naser-Aldin Lashgari
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evaluation of acute and sub-chronic oral toxicities of Neoneaster in rats

Journal of Ethnopharmacology
2023 | Journal article
EID:

2-s2.0-85151727855

Part of ISSN: 18727573 03788741
Contributors: Aramipour, N.; Gholami, M.; Saber, M.; Jafar Gandomi, S.; Lashgari, N.-A.; Sadri, A.; Sabzevari, O.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 2)‎

Evaluation of Acute and Sub-Chronic Oral Toxicity of Purgative Manna In Rats

SSRN
2023 | Other
EID:

2-s2.0-85150178655

Part of ISSN: 15565068
Contributors: Aramipour, N.; Gholami, M.; Saber, M.; Gandomi, S.J.; Lashgari, N.-A.; Sadri, A.; Sabzevari, O.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

IDO/Kynurenine; novel insight for treatment of inflammatory diseases

Cytokine
2023 | Journal article
EID:

2-s2.0-85153612917

Part of ISSN: 10960023 10434666
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Shayan, M.; Niazi Shahraki, F.; hosseini, Y.; Momtaz, S.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Juglone Mediates Inflammatory Bowel Disease Through Inhibition of TLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
2023 | Journal article
EID:

2-s2.0-85178655429

Part of ISSN: 1875614X 18715230
Contributors: Nobakht, N.A.A.; Lashgari, N.-A.; Roudsari, N.M.; Niknejad, A.; Khayatan, D.; Tavakoli, S.; Abdollahi, A.R.; Esmaealzadeh, N.; Momtaz, S.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Licofelone Attenuates Acetic Acid-Induced Colitis in Rats Through Suppression of the Inflammatory Mediators

Inflammation
2023 | Journal article
EID:

2-s2.0-85160217552

Part of ISSN: 15732576 03603997
Contributors: Shahraki, F.N.; Momtaz, S.; Baeeri, M.; Khayatan, D.; Lashgari, N.-A.; Roudsari, N.M.; Abdollahi, A.R.; Dehpour, A.R.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Management of Hemorrhagic Fever Viruses: Intervention of Natural and Synthetic Products

Mini-Reviews in Medicinal Chemistry
2023 | Journal article
EID:

2-s2.0-85168794256

Part of ISSN: 18755607 13895575
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Khayatan, D.; Samani, N.; Rad, N.E.; Mortazavi, M.; Abdolghaffari, A.H.; Momtaz, S.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Quinidine

Encyclopedia of Toxicology, Fourth Edition: Volume 1-9
2023 | Book chapter
EID:

2-s2.0-85188105856

Part of ISBN: 9780128243152
Contributors: Lashgari, N.-A.; Shayan, M.; shamsnia, H.; Roudsari, N.M.; Momtaz, S.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Regulatory Mechanisms of Vanillic Acid in Cardiovascular Diseases: A Review

Current Medicinal Chemistry
2023 | Journal article
EID:

2-s2.0-85152686439

Part of ISSN: 1875533X 09298673
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Abdolghaffari, A.H.; Atkin, S.L.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Repurposing antiparasitic drugs for the treatment of other diseases

Advances in Antiparasitic Therapies and Drug Delivery
2023 | Book chapter
EID:

2-s2.0-85191469122

Contributors: Lashgari, N.-A.; Roudsari, N.M.; Ahmadvand, D.; Amirlou, D.; Khales, S.D.; Ahmadian, D.; Momtaz, S.; Abdolghaffari, A.H.; Jamialahmadi, T.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

Inflammopharmacology
2023 | Journal article
EID:

2-s2.0-85144973014

Part of ISSN: 15685608 09254692
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Zadeh, S.S.T.; Momtaz, S.; Abbasifard, M.; Reiner, Ž.; Abdolghaffari, A.H.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Statins: Beneficial Effects in Treatment of COVID-19

Advances in Experimental Medicine and Biology
2023 | Book chapter
EID:

2-s2.0-85163657089

Part of ISSN: 22148019 00652598
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Shamsnia, H.; Shayan, M.; Momtaz, S.; Abdolghaffari, A.H.; Matbou Riahi, M.; Jamialahmadi, T.; Guest, P.C.; Reiner, Ž. et al.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

TLR/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia

Canadian Journal of Physiology and Pharmacology
2023 | Journal article
EID:

2-s2.0-85183148438

Part of ISSN: 12057541 00084212
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Shamsnia, H.S.; Shayan, M.; Momtaz, S.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 2)‎

Where do we stand? Insight on patented products and those under clinical trials

Advances in Antiparasitic Therapies and Drug Delivery
2023 | Book chapter
EID:

2-s2.0-85191491787

Contributors: Lashgari, N.-A.; Roudsari, N.M.; Shamsnia, H.S.; Koolivand, Z.; Momtaz, S.; Abdolghaffari, A.H.; Jamialahmadi, T.; Kesharwani, P.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Ginger and its constituents: Role in treatment of inflammatory bowel disease

BioFactors
2022 | Journal article
EID:

2-s2.0-85120800376

Part of ISSN: 18728081 09516433
Contributors: Lashgari, N.-A.; Momeni Roudsari, N.; Khayatan, D.; Shayan, M.; Momtaz, S.; Roufogalis, B.D.; Abdolghaffari, A.H.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 2)‎

Licofelone attenuates the acetic acid-induced colitis in rats through suppression of the inflammatory mediators

Research Square
2022 | Other
EID:

2-s2.0-85167382973

Contributors: Shahraki, F.N.; Khayatan, D.; Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Dehpour, A.R.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Antibiotics with therapeutic effects on spinal cord injury: a review

Fundamental and Clinical Pharmacology
2021 | Journal article
EID:

2-s2.0-85092536929

Part of ISSN: 14728206 07673981
Contributors: Afshari, K.; Momeni Roudsari, N.; Lashgari, N.-A.; Haddadi, N.-S.; Haj-Mirzaian, A.; Hassan Nejad, M.; Shafaroodi, H.; Ghasemi, M.; Dehpour, A.R.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations

Molecular Biology Reports
2021 | Journal article
EID:

2-s2.0-85098935038

Part of ISSN: 15734978 03014851
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Zandi, N.; Pazoki, B.; Rezaei, A.; Hashemi, M.; Momtaz, S.; Rahimi, R.; Shayan, M.; Dehpour, A.R. et al.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Ginger: A complementary approach for management of cardiovascular diseases

BioFactors
2021 | Journal article
EID:

2-s2.0-85112357302

Part of ISSN: 18728081 09516433
Contributors: Roudsari, N.M.; Lashgari, N.-A.; Momtaz, S.; Roufogalis, B.; Abdolghaffari, A.H.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Inhibitors of the PI3K/Akt/mTOR pathway in prostate cancer chemoprevention and intervention

Pharmaceutics
2021 | Journal article
EID:

2-s2.0-85112414519

Part of ISSN: 19994923
Contributors: Roudsari, N.M.; Lashgari, N.-A.; Momtaz, S.; Abaft, S.; Jamali, F.; Safaiepour, P.; Narimisa, K.; Jackson, G.; Bishayee, A.; Rezaei, N. et al.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 3)‎

Prospects of saffron and its derivatives in Alzheimer's disease

Archives of Iranian Medicine
2021 | Journal article
EID:

2-s2.0-85105037818

Part of ISSN: 17353947 10292977
Contributors: Zandi, N.; Pazoki, B.; Roudsari, N.M.; Lashgari, N.-A.; Jamshidi, V.; Momtaz, S.; Abdolghaffari, A.H.; Akhondzadeh, S.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Targeting mammalian target of rapamycin: Prospects for the treatment of inflammatory bowel diseases

Current Medicinal Chemistry
2021 | Journal article
EID:

2-s2.0-85104404536

Part of ISSN: 1875533X 09298673
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Ghanaatian, N.; Kohansal, P.; Farzaei, M.H.; Afshari, K.; Sahebkar, A.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier
grade
Preferred source (of 2)‎

The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease

Journal of Neuroimmunology
2021 | Journal article
EID:

2-s2.0-85118245194

Part of ISSN: 18728421 01655728
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Sathyapalan, T.; Abdolghaffari, A.H.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment

World Journal of Gastroenterology
2021 | Journal article
EID:

2-s2.0-85121839260

Part of ISSN: 22192840 10079327
Contributors: Lashgari, N.-A.; Roudsari, N.M.; Momtaz, S.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Dietary Fiber and Aging

Nutrients and Nutraceuticals for Active and Healthy Ageing
2020 | Book chapter
EID:

2-s2.0-85142679855

Contributors: Abdolghaffari, A.H.; Farzaei, M.H.; Lashgari, N.-A.; Roudsari, N.M.; Haddadi, N.-S.; Singh, A.K.; Rana, H.K.; Pandey, A.K.; Momtaz, S.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

PPARγ: A turning point for irritable bowel syndrome treatment

Life Sciences
2020 | Journal article
EID:

2-s2.0-85088131358

Part of ISSN: 18790631 00243205
Contributors: Roudsari, N.M.; Lashgari, N.-A.; Zandi, N.; Pazoki, B.; Momtaz, S.; Sahebkar, A.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets

Journal of Cellular Physiology
2019 | Journal article
EID:

2-s2.0-85058157855

Part of ISSN: 10974652 00219541
Contributors: Ghanaatian, N.; Lashgari, N.-A.; Abdolghaffari, A.H.; Rajaee, S.M.; Panahi, Y.; Barreto, G.E.; Butler, A.E.; Sahebkar, A.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review

DARU, Journal of Pharmaceutical Sciences
2019 | Journal article
EID:

2-s2.0-85068883824

Part of ISSN: 20082231 15608115
Contributors: Roudsari, N.M.; Lashgari, N.-A.; Momtaz, S.; Farzaei, M.H.; Marques, A.M.; Abdolghaffari, A.H.
Source: Self-asserted source
Naser-Aldin Lashgari via Scopus - Elsevier

Peer review (3 reviews for 2 publications/grants)

Review activity for Brain disorders. (1)
Review activity for Journal of ethnopharmacology. (2)